Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
15,401,638
-
Share change
-
-892,597
-
Total reported value
-
$49,434,995
-
Put/Call ratio
-
0%
-
Price per share
-
$3.21
-
Number of holders
-
88
-
Value change
-
-$2,832,059
-
Number of buys
-
32
-
Number of sells
-
40
Institutional Holders of ENDOCYTE INC - COM (ECYT) as of Q2 2016
As of 30 Jun 2016,
ENDOCYTE INC - COM (ECYT) was held by
88 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,401,638 shares.
The largest 10 holders included
FMR LLC, BlackRock Fund Advisors, VANGUARD GROUP INC, BAKER BROS. ADVISORS LP, PINNACLE ASSOCIATES LTD, JPMORGAN CHASE & CO, MILLENNIUM MANAGEMENT LLC, STATE STREET CORP, BlackRock Institutional Trust Company, N.A., and NORTHERN TRUST CORP.
This page lists
88
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.